Utility assessment among patients with dry eye disease
- PMID: 12867401
- DOI: 10.1016/S0161-6420(03)00462-7
Utility assessment among patients with dry eye disease
Abstract
Purpose: To determine utilities (patient preferences) for dry eye disease.
Design: Survey study.
Participants: Fifty-six patients with mild, moderate, or severe dry eye treated by ophthalmologists in the Eye Care Services department of Henry Ford Health Care System.
Testing: Patients completed interactive software utility assessment questionnaires by the time trade-off (TTO) method. Utility scores were scaled such that a score of 1.0 = perfect health and 0 = death. Dry eye severity was independently classified using clinical parameters and physician/patient assessments. Global health status, visual functioning, and ocular symptoms were assessed by the Short Form-36 Health Survey, 25-Item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), and Ocular Surface Disease Index survey instruments.
Main outcome measures: Utility scores for a range of dry eye severity states. These utilities were compared with utilities reported for other disease states. Correlations with the general and vision-related health status measures were conducted.
Results: Fifty-six patients completed the utility assessments with acceptable reliability. Mean utilities for moderate (0.78) and severe dry eye (0.72) by TTO were similar to historical reports for moderate (0.75) and more severe (class III/IV) angina (0.71), respectively. Utility scores correlated with the NEI VFQ-25 composite score (rho = 0.32; P = 0.037) and with components of other health measures.
Conclusions: Utilities for the more severe forms of dry eye are in the range of conditions like class III/IV angina (0.71) that are widely recognized as lowering health utilities. Our results underscore how significantly dry eye impacts patients compared with other medical conditions.
Comment in
-
Utility assessment and dry eye disease.Ophthalmology. 2004 Apr;111(4):852-3; author reply 853. doi: 10.1016/j.ophtha.2004.01.017. Ophthalmology. 2004. PMID: 15051232 No abstract available.
Similar articles
-
Utility assessment to measure the impact of dry eye disease.Ocul Surf. 2006 Jul;4(3):155-61. doi: 10.1016/s1542-0124(12)70043-5. Ocul Surf. 2006. PMID: 16900272 Review.
-
Vision and quality-of-life.Trans Am Ophthalmol Soc. 1999;97:473-511. Trans Am Ophthalmol Soc. 1999. PMID: 10703139 Free PMC article.
-
Utility-based estimates of the relative morbidity of visual impairment and angina.Ophthalmic Epidemiol. 2000 Sep;7(3):169-85. Ophthalmic Epidemiol. 2000. PMID: 11035553
-
Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.Ophthalmology. 2006 Aug;113(8):1450-4. doi: 10.1016/j.ophtha.2006.02.060. Epub 2006 Jun 12. Ophthalmology. 2006. PMID: 16769116
-
Quality of life amongst American vs. Canadian patients with retinal diseases.Curr Opin Ophthalmol. 2010 May;21(3):227-32. doi: 10.1097/ICU.0b013e3283386706. Curr Opin Ophthalmol. 2010. PMID: 20375896 Review.
Cited by
-
New Treatment Guidelines for Sjögren's Disease.Rheum Dis Clin North Am. 2016 Aug;42(3):531-51. doi: 10.1016/j.rdc.2016.03.010. Rheum Dis Clin North Am. 2016. PMID: 27431353 Free PMC article. Review.
-
Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome.Jpn J Ophthalmol. 2010 Jul;54(4):259-65. doi: 10.1007/s10384-010-0812-2. Epub 2010 Aug 11. Jpn J Ophthalmol. 2010. PMID: 20700790
-
Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.Qual Life Res. 2012 Mar;21(2):323-34. doi: 10.1007/s11136-011-9938-z. Epub 2011 Aug 4. Qual Life Res. 2012. PMID: 21814877
-
Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom.Invest Ophthalmol Vis Sci. 2014 Feb 3;55(2):650-3. doi: 10.1167/iovs.13-13330. Invest Ophthalmol Vis Sci. 2014. PMID: 24408975 Free PMC article.
-
A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans.Invest Ophthalmol Vis Sci. 2013 Feb 19;54(2):1398-410. doi: 10.1167/iovs.12-10817. Invest Ophthalmol Vis Sci. 2013. PMID: 23361507 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical